Director/PDMR Shareholding
London, 22 May 2019
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Nikoloz Gamkrelidze | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR, CEO | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2018 work year pursuant to the executive equity compensation plan. 20% of the salary shares will vest in each of the second, third and fourth years following the work year, and the remaining 40% vest in the fifth year following the work year, subject to the terms of his service agreement. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 175,000 nil-cost options over ordinary shares in respect of deferred salary shares for the 2018 work year pursuant to the executive equity compensation plan. | ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 20 May 2019 | ||||||||
f)
| Place of the transaction | Outside of a trading venue |
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Irakli Gogia | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR, Deputy CEO - Finance and Operations | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2018 work year pursuant to the executive equity compensation plan. 20% of the salary shares will vest in each of the second, third and fourth years following the work year, and the remaining 40% vest in the fifth year following the work year, subject to the terms of his service agreement. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 53,000 nil-cost options over ordinary shares in respect of deferred salary shares for the 2018 work year pursuant to the executive equity compensation plan. | ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 20 May 2019 | ||||||||
f)
| Place of the transaction | Outside of a trading venue |
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Giorgi Mindiashvili | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR, Chief Operating Officer - Hospitals | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2018 work year pursuant to the executive equity compensation plan. 20% of the salary shares will vest in each of the second, third and fourth years following the work year, and the remaining 40% vest in the fifth year following the work year, subject to the terms of his service agreement. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 53,000 nil-cost options over ordinary shares in respect of deferred salary shares for the 2018 work year pursuant to the executive equity compensation plan. | ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 20 May 2019 | ||||||||
f)
| Place of the transaction | Outside of a trading venue |
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Nikoloz Gamkrelidze | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR, CEO | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
Shares will vest on a straight-line basis in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 111,301 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
| ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 20 May 2019 | ||||||||
f)
| Place of the transaction | Outside of a trading venue |
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Irakli Gogia | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR, Deputy CEO - Finance and Operations | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
Shares will vest on a straight-line basis in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 68,443 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
| ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 20 May 2019 | ||||||||
f)
| Place of the transaction | Outside of a trading venue |
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Giorgi Mindiashvili | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR, Chief Operating Officer - Hospitals | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
Shares will vest on a straight-line basis in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 56,365 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
| ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 20 May 2019 | ||||||||
f)
| Place of the transaction | Outside of a trading venue |
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Enrico Beridze, Head of Business Development and Strategic Marketing | ||||||||
2. | Reason for the notification | |||||||||
a) | Position / status | PDMR | ||||||||
b) | Initial notification / amendment | Initial notification | ||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Georgia Healthcare Group PLC | ||||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
| ||||||||
b) | Nature of the transaction | Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
Shares will vest on a straight-line basis in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information |
| ||||||||
| Aggregated volume
| Grant of 90,000 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
| ||||||||
| Aggregated price | n/a | ||||||||
|
|
| ||||||||
e) | Dates of the transaction | 20 May 2019 | ||||||||
f)
| Place of the transaction | Outside of a trading venue |
|
|
|
|
|
Name of authorised official of issuer responsible for making notification:
Link Company Matters Limited, Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.